# ZAYVORA MATAB OS — Post-Pilot Executive Summary & Operational Review

## 1. Executive Summary & Scale Decision

- **Product / System:** ZAYVORA MATAB OS (Standalone Autonomous AYUSH Clinical Operating System)
- **Evaluation Record ID:** `EVAL-PILOT-2026-POST01`
- **Associated Pilot Program:** `PLT-PILOT-OPD-001` (Central Matab OPD Pilot)
- **Target Release / Build:** `git:81f9fba` (Clean Prompt 14 Verified Repository)
- **Evaluation Period:** October 1, 2026 to October 13, 2026 (13 days of controlled pilot operations)
- **Evaluation Status:** **`READY_FOR_DECISION`** (Assessable with limitations clearly demarcated)
- **Primary Governance Recommendation:** **`EXPAND_WITHIN_APPROVED_SCOPE`**
- **Allowed Scale Vector:** Additional certified Tabib practitioners at Central Matab OPD (`fac-central-opd`).
- **Prohibited Scale Vectors:** Live external ABDM Gateway exchange and direct public SMS provider gateways remain strictly **GATED / DISABLED** until official production credentials and facility agreements are finalized.

---

## 2. Evidence-Based Operational Review Principles

This operational review was conducted under strict evidence-based principles:

1. **No Synthetic Assumption of Efficacy:** Routine clinical usage telemetry does not infer clinical efficacy or causal patient benefit. Treatment outcomes are descriptive monitoring only.
2. **Missing Telemetry Demarcation:** Missing telemetry is explicitly categorized as `UNAVAILABLE` rather than assuming zero errors or 100% compliance.
3. **Fail-Closed Safety Invariant:** No favorable average operational metric overrides an open P0 critical defect or safety firewall bypass.
4. **Independent Expansion Gates:** Gate verification for one vector (e.g., additional OPD practitioners) does not authorize unrelated modules (e.g., Inpatient IPD or Pharmacy wholesale dispensing).
5. **Tri-Party Sign-off Mandate:** Scale decisions require tripartite approval from Clinical Governance, Product Operations, and Security & Privacy leadership.

---

## 3. High-Level Adoption Scorecard Summary

| Domain Category | Evaluated Metrics | Status Summary | Findings & Observations |
| :--- | :---: | :---: | :--- |
| **A. Workflow Usability** | 2 | **PASS (80.0% – 92.5%)** | OPD consultation workflow successfully completed across all active encounters without abandonment. Average consultation duration: 11.4 mins. |
| **B. Reliability** | 2 | **PASS (100.0%)** | Zero database rollbacks on encounter saves. 100% of signed prescriptions generated valid immutable 64-character SHA-256 fingerprints. |
| **C. Clinical Workflow Integrity** | 2 | **PASS (100.0%)** | 100% of finalized orders signed by human clinician PIN with tamper-evident audit logging. Zero orphan records or MRN mismatches. |
| **D. Safety & Governance** | 2 | **PASS (100.0%)** | 100% compliance on Schedule E(1) Mudabbar detoxification requirements. Zero open P0 safety incidents in the governance queue. |
| **E. Training & Adoption** | 2 | **PASS (100.0%)** | 100% of enrolled clinical staff passed role-based scenario exams (>=80% threshold). All 13 facility onboarding stages completed. |
| **F. Support & Operations** | 2 | **PASS (100.0%)** | Zero open P0/P1 support tickets. Zero-downtime hot database backup (`VACUUM INTO`) drill verified. |
| **G. Communications & Interop** | 1 | **HARNESS VERIFIED** | FHIR R4 document bundle exporter and ABDM contract test harness passed 100% schema validation. External production gateway remains disconnected. |
| **H. Clinical Outcomes** | 1 | **DESCRIPTIVE ONLY** | Follow-up outcome monitoring achieved 72.0% recording completeness. Strictly noted as descriptive continuity without causal efficacy inference. |

---

## 4. Key Incident & Risk Findings

1. **Safety Incident Re-Review:**
   - Total Safety Queue Incidents: 0 open (`PENDING_REVIEW` = 0).
   - Past Near-Misses: 1 flagged item regarding pediatric dosing limit on *Hab-e-Suranjan* correctly blocked by Clinical Safety Firewall in preflight stage. No patient harm occurred. Fail-closed semantics verified.
2. **Security & Privacy Re-Review:**
   - Multi-tenant cross-organization isolation verified with 0 permission bypass attempts.
   - Zero patient-identifying data exposed in public queue displays or administrative audit summaries.
3. **Operational Workarounds:**
   - Reception staff noted manual verification of appointment tokens when patients arrived earlier than slot time; resolved via queue token check-in transition.

---

## 5. Formal Scale Decision & Allowed Scope

### Decision: `EXPAND_WITHIN_APPROVED_SCOPE`

- **Authorized Facilities:** Central Matab OPD (`fac-central-opd`)
- **Authorized Practitioners:** Dr. Hakim Zafar, Dr. Hakim Tariq, Dr. Ayesha Siddiqui
- **Authorized Modules:** Master Patient Index (MPI), Consultation Workspace, Unani Assessment, Modern Assessment, Formulary Catalog, Prescriptions Engine with PIN Signing, Clinic Queue & Billing Ledger.
- **Explicitly Disabled Modules:**
  - Live ABDM Gateway (`BLOCKED_BY_EXTERNAL_DEPENDENCY`)
  - External WhatsApp/SMS Gateway (`CONFIGURED_NOT_CONNECTED`)
  - Live Inpatient IPD Bed Allocation (`GATED_STAGE_2`)
- **Next Governance Review Date:** November 15, 2026
